Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2681.45 and 2731.45
| Intraday Target 1 | 2640.97 |
| Intraday Target 2 | 2671.93 |
| Intraday Target 3 | 2690.9666666667 |
| Intraday Target 4 | 2721.93 |
| Intraday Target 5 | 2740.97 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 17 August 2026 | 2702.90 (0.52%) | 2688.00 | 2660.00 - 2710.00 | 1.4222 times | Fri 14 August 2026 | 2688.80 (0.79%) | 2667.00 | 2648.00 - 2697.00 | 1.6012 times | Thu 13 August 2026 | 2667.70 (1.81%) | 2620.00 | 2606.40 - 2677.00 | 1.0011 times | Wed 12 August 2026 | 2620.20 (0.7%) | 2601.00 | 2579.50 - 2624.90 | 1.0914 times | Tue 11 August 2026 | 2601.90 (0.03%) | 2617.00 | 2577.00 - 2617.00 | 0.5743 times | Mon 10 August 2026 | 2601.00 (0.05%) | 2595.80 | 2576.10 - 2614.70 | 0.4936 times | Fri 07 August 2026 | 2599.70 (0.78%) | 2570.00 | 2556.50 - 2624.90 | 0.5901 times | Thu 06 August 2026 | 2579.50 (0.38%) | 2546.90 | 2540.50 - 2591.00 | 0.6806 times | Wed 05 August 2026 | 2569.70 (-2.92%) | 2648.00 | 2515.00 - 2650.20 | 0.8635 times | Tue 04 August 2026 | 2647.00 (-0.57%) | 2680.20 | 2601.30 - 2684.00 | 1.6819 times | Mon 03 August 2026 | 2662.30 (0.26%) | 2665.40 | 2630.00 - 2670.00 | 1.5077 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2681.45 and 2731.45
| Weekly Target 1 | 2640.97 |
| Weekly Target 2 | 2671.93 |
| Weekly Target 3 | 2690.9666666667 |
| Weekly Target 4 | 2721.93 |
| Weekly Target 5 | 2740.97 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 17 August 2026 | 2702.90 (0.52%) | 2688.00 | 2660.00 - 2710.00 | 0.1963 times | Fri 14 August 2026 | 2688.80 (3.43%) | 2595.80 | 2576.10 - 2697.00 | 0.6572 times | Fri 07 August 2026 | 2599.70 (-2.1%) | 2665.40 | 2515.00 - 2684.00 | 0.7347 times | Fri 31 July 2026 | 2655.40 (5.61%) | 2524.00 | 2494.10 - 2679.00 | 0.9682 times | Fri 24 July 2026 | 2514.30 (2.42%) | 2454.50 | 2445.40 - 2570.00 | 0.757 times | Fri 17 July 2026 | 2454.80 (0.68%) | 2439.90 | 2406.30 - 2527.00 | 0.9536 times | Fri 10 July 2026 | 2438.20 (1.78%) | 2390.20 | 2370.00 - 2460.80 | 0.6759 times | Fri 03 July 2026 | 2395.50 (1.73%) | 2347.80 | 2335.40 - 2504.70 | 1.4756 times | Thu 25 June 2026 | 2354.80 (0.98%) | 2358.10 | 2322.30 - 2404.80 | 1.0916 times | Fri 19 June 2026 | 2332.00 (9.92%) | 2135.10 | 2111.00 - 2350.00 | 2.4899 times | Fri 12 June 2026 | 2121.50 (-1.97%) | 2154.70 | 2088.10 - 2216.00 | 1.9411 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2608.95 and 2803.95
| Monthly Target 1 | 2447.63 |
| Monthly Target 2 | 2575.27 |
| Monthly Target 3 | 2642.6333333333 |
| Monthly Target 4 | 2770.27 |
| Monthly Target 5 | 2837.63 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 17 August 2026 | 2702.90 (1.79%) | 2665.40 | 2515.00 - 2710.00 | 0.4044 times | Fri 31 July 2026 | 2655.40 (8.37%) | 2476.80 | 2370.00 - 2679.00 | 1.0048 times | Tue 30 June 2026 | 2450.30 (10.86%) | 2200.00 | 2088.10 - 2460.90 | 1.8059 times | Fri 29 May 2026 | 2210.20 (-5.4%) | 2342.00 | 2194.40 - 2520.00 | 1.2513 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.7707 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.621 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.9062 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8095 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.3229 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.1034 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7165 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2395.5 and 3027.2
| Yearly Target 1 | 1871.9 |
| Yearly Target 2 | 2287.4 |
| Yearly Target 3 | 2503.6 |
| Yearly Target 4 | 2919.1 |
| Yearly Target 5 | 3135.3 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 17 August 2026 | 2702.90 (9.27%) | 2476.00 | 2088.10 - 2719.80 | 0.6843 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.5277 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.149 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.1946 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.6939 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9255 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0329 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4418 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2247 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1257 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1259 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. But this trend seems to be weakening.
Price is above an important level of 2631.73 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 60 as on Mon 17 August 2026
This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.
SMA20 is at 2605 and price is deviating by 58 points
Upper Bollinger band is at 2721 and lower is at 2489, while middle bands are at 2547 and 2663
Price is rising
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2641.87 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2656.3 |
| 12 day DMA | 2633.01 |
| 20 day DMA | 2604.29 |
| 35 day DMA | 2534.91 |
| 50 day DMA | 2449.18 |
| 100 day DMA | 2402.55 |
| 150 day DMA | 2426.31 |
| 200 day DMA | 2453.91 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2666.33 | 2648.05 | 2627.68 |
| 12 day EMA | 2631.71 | 2618.77 | 2606.04 |
| 20 day EMA | 2596.27 | 2585.05 | 2574.13 |
| 35 day EMA | 2523.52 | 2512.96 | 2502.61 |
| 50 day EMA | 2448.19 | 2437.8 | 2427.56 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2656.3 | 2635.92 | 2618.1 |
| 12 day SMA | 2633.01 | 2625.33 | 2620.13 |
| 20 day SMA | 2604.29 | 2593.3 | 2581.6 |
| 35 day SMA | 2534.91 | 2524.95 | 2515.41 |
| 50 day SMA | 2449.18 | 2438.4 | 2427.96 |
| 100 day SMA | 2402.55 | 2399.28 | 2396.77 |
| 150 day SMA | 2426.31 | 2424.84 | 2423.29 |
| 200 day SMA | 2453.91 | 2454.19 | 2454.55 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 61.15 and PE is: 44.2
Last quarter profit: (March 2026 quarter) 277.86 crores (5.70%)
Debt: 33.27 in crores
Market capitalization: 39891.73
EPS is 60.27 and PE is: 44.85
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
